| Pfizer AG - Ngenla 60 mg/ 1.2 ml, Injektionslösung im Fertigpen | | 68265 | | 02 | | Ngenla 60 mg/ 1.2 ml | | Injektionslösung im Fertigpen | | H01AC08 | | | | 09.09.2022 | | |
| | Composition | | somatrogonum 60 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, metacresolum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml corresp. natrium 4.8 mg. | | Packungsbestandteile | | | | | | | | | | Active Agent | Dose |
|---|
| | 60mg / 1.2ml |
| | BAG: Active Agent | Dose |
|---|
| | 60 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Histidine | | | Metacresol | | | Sodium Chloride | | | Natrii Citras Dihydricus | | | Poloxamer | 188 |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 1.2 ml | 711.50 | 790.20 | A | SL | No |
|
|
